These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23349391)

  • 1. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.
    Schwoebel F; van Eijk LT; Zboralski D; Sell S; Buchner K; Maasch C; Purschke WG; Humphrey M; Zöllner S; Eulberg D; Morich F; Pickkers P; Klussmann S
    Blood; 2013 Mar; 121(12):2311-5. PubMed ID: 23349391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron sequestration and anemia of inflammation.
    Ganz T; Nemeth E
    Semin Hematol; 2009 Oct; 46(4):387-93. PubMed ID: 19786207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats.
    Theurl I; Schroll A; Sonnweber T; Nairz M; Theurl M; Willenbacher W; Eller K; Wolf D; Seifert M; Sun CC; Babitt JL; Hong CC; Menhall T; Gearing P; Lin HY; Weiss G
    Blood; 2011 Nov; 118(18):4977-84. PubMed ID: 21730356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.
    Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T
    J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
    Kuo HC; Yang YL; Chuang JH; Tiao MM; Yu HR; Huang LT; Yang KD; Chang WC; Lee CP; Huang YH
    J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.
    Sun CC; Vaja V; Babitt JL; Lin HY
    Am J Hematol; 2012 Apr; 87(4):392-400. PubMed ID: 22290531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.
    Hashizume M; Uchiyama Y; Horai N; Tomosugi N; Mihara M
    Rheumatol Int; 2010 May; 30(7):917-23. PubMed ID: 19639319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.
    Ganz T
    Blood; 2003 Aug; 102(3):783-8. PubMed ID: 12663437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid anemia.
    Masson C
    Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
    Song SN; Tomosugi N; Kawabata H; Ishikawa T; Nishikawa T; Yoshizaki K
    Blood; 2010 Nov; 116(18):3627-34. PubMed ID: 20644113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways.
    Shin DY; Chung J; Joe Y; Pae HO; Chang KC; Cho GJ; Ryter SW; Chung HT
    Blood; 2012 Mar; 119(11):2523-32. PubMed ID: 22262759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.
    Steinbicker AU; Sachidanandan C; Vonner AJ; Yusuf RZ; Deng DY; Lai CS; Rauwerdink KM; Winn JC; Saez B; Cook CM; Szekely BA; Roy CN; Seehra JS; Cuny GD; Scadden DT; Peterson RT; Bloch KD; Yu PB
    Blood; 2011 May; 117(18):4915-23. PubMed ID: 21393479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia of inflammation: the cytokine-hepcidin link.
    Andrews NC
    J Clin Invest; 2004 May; 113(9):1251-3. PubMed ID: 15124013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.
    van Eijk LT; John AS; Schwoebel F; Summo L; Vauléon S; Zöllner S; Laarakkers CM; Kox M; van der Hoeven JG; Swinkels DW; Riecke K; Pickkers P
    Blood; 2014 Oct; 124(17):2643-6. PubMed ID: 25163699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.
    Rivera S; Nemeth E; Gabayan V; Lopez MA; Farshidi D; Ganz T
    Blood; 2005 Sep; 106(6):2196-9. PubMed ID: 15933050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.
    Lepanto MS; Rosa L; Cutone A; Conte MP; Paesano R; Valenti P
    Front Immunol; 2018; 9():2123. PubMed ID: 30298070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine formation of hepcidin induces iron retention in human monocytes.
    Theurl I; Theurl M; Seifert M; Mair S; Nairz M; Rumpold H; Zoller H; Bellmann-Weiler R; Niederegger H; Talasz H; Weiss G
    Blood; 2008 Feb; 111(4):2392-9. PubMed ID: 18073346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
    Vadhan-Raj S; Abonour R; Goldman JW; Smith DA; Slapak CA; Ilaria RL; Tiu RV; Wang X; Callies S; Cox J; Tuttle JL; Lau YK; Roeland EJ
    J Hematol Oncol; 2017 Mar; 10(1):73. PubMed ID: 28327200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.
    Roy CN; Mak HH; Akpan I; Losyev G; Zurakowski D; Andrews NC
    Blood; 2007 May; 109(9):4038-44. PubMed ID: 17218383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.